News | May 07, 2012

India's Bhubaneswar Borooah Cancer Institute Acquires New Linac

May 7, 2012 — Prime Minister of India Manmohan Singh honored the Bhubaneswar Borooah Cancer Institute (BBCI) by presiding over the inauguration of its Elekta Synergy linear accelerator on April 20 in Guwahati in the Indian state of Assam. The Synergy system joins BCCI's first Elekta treatment system, which was installed in 2000. Established in 1973, the BBCI is among the leading cancer institutes of east India and was recognized as a Regional Cancer Centre in 1980.

"It was very gratifying to have an influential public figure such as Dr. Singh recognize the importance of increasing access to medical technology in India — which will hopefully influence the decision-making process at other regional hospitals that are seeking to invest in linear accelerators," said Brendhan Vahey, managing director, Elekta India.

Elekta and other healthcare providers have partnered with medical centers and clinics across India to address a serious shortage of radiation therapy equipment. India's population of 1.21 billion significantly dwarfs the number of radiotherapy systems available to its residents, Vahey adds.

"To match a developed nation's ratio of inhabitants to linear accelerators alone, India would need about 10 times as many treatment systems," he said. "Fortunately, the Indian radiation therapy market is growing at an unprecedented rate — over 15 percent per year — almost double its current GDP growth."

BBCI's new Synergy system is fully equipped with the most advanced radiation therapy techniques in use today, including intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).

In Assam, head-and-neck cancer and tobacco-related cancers (mainly lung cancer) comprise 15-20 percent of total cancers. Among males, the top three cancer incidences are oral cavity, larynx and lung cancer, while in women, cervical and breast cancers are the most common. In metro areas, prostate and breast cancer incidences are rising. At any given time in India, there are about three million individuals who have cancer, with approximately 960,000 new cases identified per year. A national task force estimates that two-thirds of those diagnosed with cancer will need radiation therapy.

"We will continue to see a tremendous need for cancer care in India for many years to come," Vahey said. "As a leading supplier of comprehensive solutions for cancer management in India, it is Elekta's responsibility to work closely with healthcare professionals to make these advanced solutions available to the public."

For more information: www.elekta.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init